Pacific Biosciences of California, Inc.
- Industry Biotechnology
- Sector Healthcare
- Market Cap
- Earnings
About
Profile
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
PACB
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Pacific Biosciences of California Non-GAAP EPS of -$0.27 beats by $0.02, revenue of $55.69M beats by $7.06M
- Pacific Biosciences of California Q3 2023 Earnings Preview
- Canaccord sees solid Q3 earnings for medtech; likes Quanterix, Natera, Guardant
- PacBio files for sale of 8.99M shares by selling stockholders
- Bernstein bullish on Thermo, Revvity, Guardant, PacBio; bearish on Illumina
- PacBio announces Pacbio Capital
- AI to represent 11% of healthcare budgets in 2024 - Morgan Stanley
- PacBio up 5% after hours on narrowing quarterly EPS loss, consensus beats
- PacBio buying Apton Biosystems in up to $110M deal
- Pacific Biosciences of California Non-GAAP EPS of -$0.26 beats by $0.05, revenue of $47.57M beats by $7.66M
- Pacific Biosciences of California Q2 2023 Earnings Preview
- PacBio initiated at buy at Goldman on sequencing system
- PacBio launches exchange transaction with noteholder
- PacBio equal weight at Barclays on tough macro environment
- PacBio sees quarterly net loss widen as it misses on bottom line
- Pacific Biosciences of California GAAP EPS of -$0.36 misses by $0.03, revenue of $38.9M beats by $4.52M
- Pacific Biosciences of California Q1 2023 Earnings Preview
- Hot Stocks: DWAC rises on Trump's indictment; PACB jumps on analyst upgrade; NKLA and GNRC plunges on downgrade; MU slides on regulators scrutiny
- PacBio upgraded to buy at Cowen on 'growth transformation story'
- PacBio to commence commercial shipment of Revio Systems